SCHEMBL9509070

SCHEMBL9509070

CCCc1c(OCCCCCCc2cccc(O)c2O)ccc(C(=O)O)c1OC(C)=O

nearest known ligand 0.78

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 7/20 0.50
CYSLTR1 Q9Y271 7/20 0.50
GRM2 Q14416 1/20 0.47
LTB4R Q15722 1/20 0.45
LTB4R2 Q9NPC1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9506867 0.88 GRM2 (0.54) CYSLTR2CYSLTR1GRM2LTB4RLTB4R2
SCHEMBL9508106 0.88 GRM2 (0.54) CYSLTR2CYSLTR1GRM2LTB4RLTB4R2
SCHEMBL7777769 0.88 GRM2 (0.54) CYSLTR2CYSLTR1GRM2LTB4RLTB4R2
SCHEMBL9506699 0.87 GRM2 (0.55) CYSLTR2CYSLTR1GRM2
SCHEMBL9506821 0.84 CYSLTR2 (0.52) CYSLTR2CYSLTR1GRM2
SCHEMBL9506752 0.84 CYSLTR2 (0.48) CYSLTR2CYSLTR1GRM2
SCHEMBL9508067 0.82 GRM2 (0.61) CYSLTR2CYSLTR1GRM2
SCHEMBL9508108 0.81 PPARA (0.50) CYSLTR2CYSLTR1GRM2
SCHEMBL9325728 0.79 BID (0.52)
SCHEMBL9326927 0.79 BID (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0310126-B1 DERIVATIVES OF PYROCATECHOL-CARBOXYLIC ACID, THEIR PREPARATION AND USE AS ACTIVE INGREDIENTS IN MEDICINES F. HOFFMANN-LA ROCHE AG (CH) 1993-08-18 EP disclosed
US-5191108-A Lipoxygenase inhibitors, antiinflammatory agents HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US disclosed
US-5025036-A Antiinflammatory agents, gastrointestinal, cardiovascular and skin disorders HOFFMANN-LA ROCHE INC. (US) 1991-06-18 US disclosed
EP-0310126-A2 Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines F. HOFFMANN-LA ROCHE AG (CH) 1989-04-05 EP disclosed